“…50% of AN patients will develop bulimic symptoms and migrate to a binge/purge subtype of AN and one third of those with BN have a history of AN (Bulik et al, 1997b;Eckert et al, 1995;Eddy et al, 2007;Eddy et al, 2002;Strober et al, 1997;Tozzi et al, 2005 SMR BN: 2.0 (95% CI) Prevalence Prevalence AN: 0.2 and 0.5% BN: 1.1-4.2% Course and outcome Course and outcome AN: less favourable than BN (Fichter & Quadflieg, 2004) BN: more favourable than AN (Fichter & Quadflieg, 2004) Addiction Liability Addiction Liability AN: AN-R shows significantly less drug-consumption behaviours and alcohol abuse (Corcos et al, 2001) BN: BN shows a significantly higher risk of developing a psychoactive substance dependence during his/her lifetime. (Bulik, 1987;Bulik et al, 1997a;Dansky et al, 2000;Goodman, 2007;Herzog et al, 2006;Holderness et al, 1994;Jones et al, 1985;Lacey, 1993;Mitchell et al, 1985;Mitchell et al, 1991;Welch & Fairburn, 1996;Wilson, 1992) Genetics Genetics Linkage analysis: less number of linkage signals, with minimal overlap with BN (Bacanu et al, 2005) Linkage analysis: greater number of linkage signals, with minimal overlap with AN (Bacanu et al, 2005) Susceptibility locus: chromosome 1 (Grice et al, 2002), 2, and 13 (Devlin et al, 2002) with inclusion of core behavioural covariates Susceptibility locus: chromosome 10p,with a suggestive linkage on chromosome 14 (Bulik et al, 2003 …”